Research News & Publications

Researchers report how molecular partners form dynamic scaffolding for protein machinery

12/05/2018

Scientific discovery by St. Jude group could lead to new pathway for cancer treatment and understanding of ALS.
St. Jude research into leukemia, sickle cell and other blood disorders presented at ASH

11/30/2018

The 2018 annual meeting of the American Society of Hematology will include research from St. Jude that stretches from the laboratory to the clinic.
St. Jude at the American Society of Hematology (ASH) 2018 annual meeting

11/28/2018

St. Jude scientists and clinicians highlighted at the annual American Society of Hematology in San Diego. Read the latest.
St. Jude announces extensive resource to advance leukemia research

11/14/2018

The Public Resource of Patient-derived and Expanded Leukemias (PROPEL) offers patient-derived xenograft samples free of charge for researchers worldwide.
Researchers reveal why Hippo pathway may have an outsized effect on solid tumor

10/30/2018

A surprising mechanism that might explain how the Hippo signaling pathway promotes solid tumor growth.
Small risks may have big impact on breast cancer odds of childhood cancer survivors

10/26/2018

Common genetic variations may help find female childhood cancer survivors at increased risk of breast cancer and who are candidates for stepped up screening.
Obesity problem starts early phase of therapy in children with acute lymphoblastic leukemia

10/25/2018

Children with ALL gain weight during treatment, and researchers suggest that early interventions should be considered.
Collaboration yields possible treatment for rare neurodegenerative disorder

10/23/2018

Read how a discovery in bacteria in the 1980s led to a promising new class of compounds for treatment of PKAN, a progressive neurodegenerative disease.
Reprogramming immune cells to fight tumors from within

10/19/2018

Scientists have a new strategy to enhance the anti-cancer immune response and slow tumor growth. The goal is to reprogram macrophages to eliminate tumor cells.
St. Jude investigators present novel pediatric cancer genome sequencing data at ASHG

10/17/2018

Presentations outline data from Genomes for Kids study, proving clinical utility of multi-platform genome sequencing for pediatric precision oncology.